ClinicalTrials.govpublic full text
Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
carcinoma, non-small-cell lung, gemcitabine, carboplatin, bevacizumab, biological therapy, drug therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911459
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.